Q3 2022 Holdings
Filed 2022-11-10 | 10 holdings | $771.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. | COM | 48576A100 | $295.3K | 1,312,872 | 38.3% |
| Eqrx, Inc. | COM | 26886C107 | $179.9K | 36,335,375 | 23.3% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $112.6K | 3,668,749 | 14.6% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $86.2K | 11,055,554 | 11.2% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $69.0K | 2,008,809 | 8.9% |
| Revolution Healthcare Acquisition Corp. | COM | 76155Y108 | $13.3K | 1,357,237 | 1.7% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $9.5K | 3,798,926 | 1.2% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $4.0K | 10,048,181 | 0.5% |
| Metacrine, Inc. | COM | 59101E103 | $1.4K | 2,940,503 | 0.2% |
| Rubius Therapeutics, Inc. | COM | 78116T103 | $152 | 349,908 | 0.0% |